VANCOUVER, BC, Sept. 11, 2020 /CNW/ – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 230 dispensaries throughout California, and over 80 dispensaries throughout Arizona, is pleased to announce that it has retained the services of Renmark Financial Communications Inc. (“Renmark“) to handle its investor relations activities.
“We are pleased to announce that we have selected Renmark to reinforce Hollister’s profile in the financial community and enhance the visibility of our company. We chose Renmark because its standards and methodologies fit best with the message we wish to communicate to the investing public,” noted Alex Somjen, President of Hollister.
In consideration of the services to be provided, the monthly fees incurred by Hollister will be a cash consideration of up to $8,000 CAD, starting October 1st, 2020 for a period of six months ending on March 31st, 2021 and monthly thereafter.
Renmark does not have any interest, directly or indirectly, in Hollister or its securities, or any right or intent to acquire such an interest.
About Hollister Biosciences Inc.
Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.
The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com
SOURCE Hollister Biosciences Inc.
For further information: HOLLISTER BIOSCIENCES INC.: Company Contact: Kelvin Lee: firstname.lastname@example.org, Tel: 604-961-0296; RENMARK FINANCIAL COMMUNICATIONS INC.: Company Contact: Melanie Barbeau: email@example.com, Tel: (416) 644-2020 or (212) 812-7680, www.renmarkfinancial.com